相关实验视频

Updated: Jan 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

通过SMAD3/CBR4通路调节皮质外围痕增生术后IFITM1的机制

Haoran Wang¹, Zekai Zhu², Jun Liu²

¹Department of Orthopaedics, Tongji Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China.

Frontiers in immunology

|September 19, 2025

概括

干扰素诱导的跨膜蛋白1 (IFITM1) 通过抑制通过SMAD3信号传递的纤维细胞增殖和通过CBR4调节调节脂肪细胞纤维化来抑制外周痕增生. 缺少IFITM1可以减少膜切除术后的痕形成.

科学领域:

细胞生物学细胞生物学
分子生物学分子生物学
手术病理学手术病理学

背景情况:

外周痕增生是拉美切除术后的常见并发症,导致持续的腰部疼痛和不良的手术结果.
纤维细胞增殖,分化和脂肪细胞纤维化与痕形成有关,但潜在的机制需要阐明.

研究的目的:

为了研究干扰素诱导的跨膜蛋白1 (IFITM1) 在拉米切除术后的外周痕增生中的作用.
阐明涉及IFITM1,SMAD3信号和CBR4在纤维细胞和脂肪细胞行为中的分子机制.

主要方法:

使用野生类型和IFITM1-淘汰赛小鼠建立了小鼠膜切除模型.
利用组织学染色 (HE,Masson),免疫光,西部斑点和共同免疫沉来分析纤维化,蛋白质表达和相互作用.
开发了体外纤维细胞和脂肪细胞模型来研究细胞过程和信号通路.

主要成果:

在小鼠中IFITM1缺乏减少了外周纤维化和纤维细胞扩散后的拉米切除术.
IFITM1表达与纤维细胞激活相关,这种激活是由SMAD3通路抑制抑制的.
通过调节CBR4,IFITM1调节脂肪细胞纤维化,IFITM1缺乏导致脂肪组织减少和痕中的CBR4表达增加.

结论:

IFITM1通过通过SMAD3信号来抑制纤维细胞增殖,在外周痕增生症中发挥着关键作用.
IFITM1通过调节CBR4表达来影响脂肪细胞纤维化,影响痕组织组成.
向IFITM1可能提供一种治疗策略,以减轻后拉美切除术外周围痕.

关键词:

CBr4 CBr4 的意思是什么如果IFITM1是IFITM1,那么它就是IFITM1.这真是太疯狂了脂肪细胞的脂肪细胞.外周周围的痕增生过度增生.纤维细胞细胞是什么?

更多相关视频

A Mouse Model of Lumbar Spine Instability

A Mouse Model of Lumbar Spine Instability

Published on: April 23, 2021

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...